Fortress Biotech (FBIO) News Today → The most important AI company you've never heard of (From Manward Press) (Ad) Free FBIO Stock Alerts $1.74 -0.02 (-1.14%) (As of 05/15/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 4:15 PM | globenewswire.comFortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsMay 15 at 4:01 PM | globenewswire.comJourney Medical Corporation to Participate in the Alliance Global Partners' (A.G.P.) Virtual Healthcare Company ShowcaseMay 14 at 8:30 AM | globenewswire.comFortress Biotech Announces First Patient Dosed in Multi-Center Phase 2 Study of Triplex for Control of CMV in Patients Undergoing Liver TransplantationMay 13 at 4:01 PM | globenewswire.comJourney Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate HighlightsMay 13 at 8:30 AM | globenewswire.comCheckpoint Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceMay 10, 2024 | globenewswire.comCheckpoint Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate UpdatesMay 7, 2024 | globenewswire.comJourney Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024May 1, 2024 | globenewswire.comJourney Medical Corporation Appoints Joseph Benesch as Chief Financial OfficerApril 25, 2024 | globenewswire.comJourney Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024April 11, 2024 | investorplace.com3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024March 29, 2024 | finanznachrichten.deFortress Biotech, Inc.: Fortress Biotech Reports 2023 Financial Results and Recent Corporate HighlightsMarch 28, 2024 | globenewswire.comFortress Biotech Reports 2023 Financial Results and Recent Corporate HighlightsMarch 28, 2024 | finanznachrichten.deMustang Bio, Inc.: Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune DiseasesMarch 28, 2024 | msn.comMustang Bio stock climbs 9% amid drug development updateMarch 22, 2024 | globenewswire.comCheckpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsMarch 21, 2024 | globenewswire.comJourney Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsMarch 18, 2024 | finance.yahoo.comAvenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate HighlightsMarch 18, 2024 | globenewswire.comJourney Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of RosaceaMarch 15, 2024 | globenewswire.comJourney Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024March 13, 2024 | globenewswire.comJourney Medical Corporation to Participate in the 36th Annual ROTH ConferenceMarch 12, 2024 | globenewswire.comFortress Biotech to Participate in 36th Annual ROTH ConferenceMarch 11, 2024 | globenewswire.comJourney Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual MeetingMarch 4, 2024 | globenewswire.comFortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes DiseaseJanuary 29, 2024 | finance.yahoo.comCheckpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-MarketJanuary 11, 2024 | finance.yahoo.comAvenue Therapeutics to Present at Sidoti January Micro-Cap Investor ConferenceJanuary 9, 2024 | finance.yahoo.comInsider Buying: President, CEO & Chairman, 10% Owner ROSENWALD LINDSAY A MD Acquires 50,000 ...January 5, 2024 | finance.yahoo.comJourney Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat RosaceaJanuary 5, 2024 | finance.yahoo.comAvenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in ProceedsJanuary 4, 2024 | finance.yahoo.comAvenue Therapeutics Reaches Final Agreement with the U.S. FDA for the Phase 3 Safety Study for IV TramadolJanuary 2, 2024 | finance.yahoo.comAvenue Therapeutics Announces Completion of Enrollment in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)December 29, 2023 | markets.businessinsider.comWhy Fortress Biotech Shares Are Tumbling TodayDecember 11, 2023 | finance.yahoo.comMustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual MeetingDecember 6, 2023 | finance.yahoo.comJourney Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat RosaceaDecember 6, 2023 | finance.yahoo.comSentynl Therapeutics Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease from Cyprium TherapeuticsDecember 6, 2023 | finance.yahoo.comCyprium Therapeutics, a Fortress Biotech Subsidiary Company, Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease, to Sentynl Therapeutics, a Wholly-owned Subsidiary of Zydus Lifesciences Ltd.December 1, 2023 | benzinga.comFortress Biotech Stock (NASDAQ:FBIO), Analyst Ratings, Price Targets, PredictionsDecember 1, 2023 | finance.yahoo.comAvenue Therapeutics to Present at American Epilepsy Society 2023 Annual MeetingNovember 29, 2023 | markets.businessinsider.comRoth MKM Maintains Buy Rating for Fortress Biotech: Here's What You Need To KnowNovember 17, 2023 | benzinga.comThinking about buying stock in Coinbase Global, Celsius Holdings, Cadence Design Systems, Coherus Biosciences, or Fortress Biotech?November 13, 2023 | finance.yahoo.comCheckpoint Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNovember 10, 2023 | marketwatch.comFortress Biotech Shares Fall Premarket on Public Offering PlansOctober 26, 2023 | finance.yahoo.comMustang Bio Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesOctober 20, 2023 | finance.yahoo.comJourney Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg)October 18, 2023 | finance.yahoo.comCheckpoint Therapeutics Announces Publication of Cosibelimab Pivotal Trial Results in the Journal for ImmunoTherapy of CancerOctober 16, 2023 | finance.yahoo.comFortress Biotech Subsidiary Helocyte Announces Option Agreement with City of Hope for Exclusive Worldwide Rights to use a Novel Bispecific CMV/HIV CAR T Cell Therapy (optionally in combination with Triplex) for the Treatment of Adults Living with HIV-1September 22, 2023 | wsj.comFortress Biotech Inc. 9.375% Cum. Pfd. Series ASeptember 13, 2023 | seekingalpha.comFortress Biotech, Inc. 9.375% CUM RED PER PREF SER A USD25.00 goes ex-dividend tomorrowSeptember 7, 2023 | finance.yahoo.comMustang Bio to Participate in Upcoming September 2023 Investor ConferencesSeptember 7, 2023 | finance.yahoo.comFortress Biotech to Present at H.C. Wainwright 25th Annual Global Investment ConferenceSeptember 6, 2023 | finance.yahoo.comJourney Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address This Wall Street stock prediction just went viral (Ad)People around the world follow 50-year Wall Street veteran Marc Chaikin for his surprisingly accurate stock predictions. And he just issued an urgent WARNING for some of the most popular stocks in U.S. history. Watch just the first 5 minutes of his new prediction FBIO Media Mentions By Week FBIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FBIO News Sentiment▼0.380.55▲Average Medical News Sentiment FBIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FBIO Articles This Week▼71▲FBIO Articles Average Week Get Fortress Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for FBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: BOLT News MTEM News BCTX News IPA News SPRB News MRKR News APLM News PMN News VIRX News CASI News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FBIO) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingAmazon's betting big on this unknown AI companyManward PressThis Wall Street stock prediction just went viralChaikin AnalyticsWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks NewsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeProtect Your Bank Account Before It’s Too LateWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.